Chairman and CEO Elias Vamvakas, TearLab Corporation Insider Buys $119,700 of Shares on May 13, 2014
Elias Vamvakas, CEO of TearLab Corporation, bought 30,000 shares of TearLab Corporation (Stock Symbol: TEAR) at $3.99 per share for a total amount of $119.7 thousand on May 13, 2014.
TearLab Corporation is headquartered in in San Diego, California.
On 06/13/2014, TearLab Corporation (“TearLab” or the “Company”) announced that all of the nominees listed in the management information circular for the annual meeting of shareholders held on Wednesday, June 11, 2014 were elected as directors of the Company.
On 05/08/2014, TearLab Corporation announced its latest quarterly results. For the three months ended March 31, 2014, TearLab’s net revenues were $4.2 million, up 70% from $2.5 million for the same period in 2013. A total of 254 orders for TearLab systems were booked in the first quarter. Of those, 201 systems were under the Company’s Masters Multi Unit Program, 40 were through its minimum use access programs, 6 were direct purchases and 7 were purchased outside of the U.S.
According to Capital IQ, TearLab Corporation has a market cap of $153.15 million, an enterprise value of $129.86 million, and trailing 12 month revenues of [Enter $16.38 million.
TearLab Corp. operates as an ophthalmic device company in the United States. It is involved in developing and commercializing TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. The companys system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, which is a single-use microfluidic microchip; TearLab pen, which is a hand-held device that interfaces with the TearLab disposable; and TearLab reader, which is a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corp. was founded in 1996 and is headquartered in San Diego, California.
Elias Vamvakas's most recent annual compensation from TearLab Corporation is a salary of [Enter $681,172], $36,691] in other compensation, and a total compensation of $717,863. Mr. Vamvakas is 54 years old.
According to his biography, Mr. Elias Vamvakas is Chairman of the Board, Chief Executive Officer of TearLab Corp. He co-founded TLC Vision, an eye care services company, where he was the Chairman from 1994 to June 2006 and was the Chief Executive Officer from 1994 to July 2004. He has been the Chairman of the Board of Directors of TearLab Corporation, or the Board, since June 2003 and was the Chief Executive Officer and Secretary of the Company from July 2004 until October 2008 and again since June 2009. Since November 30, 2006, Mr. Vamvakas has been a member of the board of directors of TearLab Research, Inc. formerly known as TearLab, Inc. and OcuSense, Inc. Mr. Vamvakas has been the chairman of the board of Greybrook Capital, a Toronto-based private equity firm. Mr. Vamvakas also serves on the boards of several of Greybrook’s portfolio companies and Jameson Bank. Mr. Vamvakas was named to “Canada’s Top Forty Under Forty” in 1996. In 1999, he was named Ernst & Young’s Entrepreneur of the Year for Ontario in the Emerging Category and Canadian Entrepreneur of the Year for Innovative Partnering. In 2000, Mr. Vamvakas was recognized by Profit Magazine for managing one of Canada’s fastest growing companies. Mr. Vamvakas received a B.Sc. degree from the University of Toronto in 1981.
All stories in DailyStocks.com are for informational purposes only. This is NOT a stock recommendation. This DailyStocks.com story is a daily light analysis featuring a stock with insider buying. With some caveats, insiders purchase a stock because they think the stock is going up. There are other factors to consider such as size of the transaction relative to their compensation and net worth. Sometimes, insiders might be propping a stock price up for future financing. Sometimes, the amount of insider buying are misread or misreported. Each month, DailyStocks releases a a summary of the stocks with insider buying. Sign up for the free monthly newsletter at DailyStocks.com .
About Dailystocks.com: DailyStocks.com is the place where you can find stories about stocks with insider buying, where you can educate yourself about stock market investing, and where you can perform the stock search engine analysis – you enter a stock symbol, and you get a resulting page of stock ticker indexed links so that you do not have to type the stock symbol each time.
Recent Comments